15% OFF + FREE SHIPPING ON ORDERS OVER $75

#1 Choice of CBD in America

CV Sciences Responds to FDA Statement | Fox & Friends

Dear Valued Partner,

We’re reaching out to address the FDA’s recent Consumer Communication and Warning Letters related to CBD. CV Sciences supports their enforcement actions against companies who make unsubstantiated claims that CBD containing products can treat cancer, Alzheimer’s disease, opioid withdrawal, etc. These companies put consumers at risk while giving responsible companies, who have done their due diligence, a black eye.

That said, we are disappointed in the alarmist tone used by the FDA in their consumer update, which was released simultaneously with the Warning Letters, regarding the safety of CBD, in that they did not differentiate the vast range of products, servings, and ingredient forms. We agree with the FDA in that there are currently products that raise safety concerns due to their high levels of CBD or that are being marketed to children. As an industry leader, CV Sciences has conducted scientific studies (CVSI GRAS + education@cvsciences.com

Sincerely,
Stuart Tomc, Vice President, Human Nutrition
CV Sciences, PlusCBD™ Oil

Is-CBD-Safe-10-facts

« All Blog Posts